Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
East Park Research is a specialized nutraceutical company focused on the research and development of olive leaf extract-based health supplements. The company is best known for its flagship product, d-Lenolate, which utilizes a patented extraction process to concentrate oleuropein for immune system support. Since its founding in 1995, East Park Research has expanded its portfolio to include topical treatments and pet health products, all centered on the antimicrobial and antiviral properties of olive leaf. The company emphasizes natural, non-toxic solutions for maintaining wellness and combating various pathogens. Their products are marketed globally to consumers seeking alternative and complementary health options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on East Park Research.